BRCA1 and breast cancer: In our population, women with BC and BRCA mutations had worse prognosis than those with sporadic cancer, diagnosed at the same age, with HR of 3.2 for BRCA1 and 2.6 for BRCA2. Goodwin et al [38] suggested that prognosis was best predicted by the characteristic of the cancer developed by each individual rather than by their carrier status.